Hodgkin lymphoma

Cancer incidence rate refers to the number of new cancers cases occurring in a specified population during a given year, expressed as the number of cancer cases per 100,000 population.¹ 

In 2018, the UK ranked 5^th amongst the 31 European countries studied for the incidence of Hodgkin lymphoma, with 3 people in every 100,000 being diagnosed with the condition (ranging from 1 case per 100,000 people in Romania to 7 per 100,000 people in Greece).

The UK's incidence rate for this cancer type was similar to the European average.

Downloads:

• Download graphs | download data  | download complete zip 

Note:

• For this cancer type there is no information available on incidence at a country level for 1995

Reference for text:

1. National Cancer Institute. Cancer Incidence Rates. 

References for graphs:

• ECIS (European Cancer Information System). Incidence and mortality estimates 2018
• ECIS (European Cancer Information System). Incidence and mortality historical data
• Engholm, G et al. NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic countries, Version 8.0 (20.12.2017)

Cancer Deaths

Cancer mortality rate refers to the number of deaths caused by cancer occurring in a specified population during a given year, expressed as the number of cancer deaths per 100,000 population.²

In 2018, the UK ranked 5^th amongst the 31 European countries studied for the mortality of Hodgkin lymphoma, with 1 in every 100,000 people dying from the condition (ranging from less than 1 death per 100,000 people in Austria to 2 per 100,000 people in Greece).

The UK's mortality rate for this cancer type was similar to the European average.

Downloads:

• Download graphs | download data  | download complete zip 

Note:

• For this cancer type there is no information available on mortality at a country level for 1995

Reference for text:

2. National Cancer Institute. Cancer Mortality Rates.

References for graphs:

• ECIS (European Cancer Information System). Incidence and mortality estimates 2018
• International Agency for Research on Cancer. WHO cancer mortality database

Survival refers to the percentage of people that were diagnosed with cancer in a given year and who are still alive after a certain period of time (here defined as 5 years or more after being diagnosed).³

Between 2010 and 2014, the UK ranked 13^th amongst the 28 European countries studied for the 5 year survival post-diagnosis of blood cancers, with 65% of people surviving 5 years or more after being diagnosed with these cancer types (ranging from 40% survival in Romania to 72% in Switzerland).

Downloads:

Notes:

• There is no country level data for these cancer types between 1995 and 1999
• There is no European average for 5-year survival because data for Greece, Hungary and Luxembourg is lacking
• Survival data was only collected for leukaemia, Non-Hodgkin lymphoma, Hodgkin lymphoma and multiple myeloma for all countries
• The latest data collected by IHE was for the 2010-2014 5-year period

Reference for text:

3. Hofmarcher, T et al. (2019) Comparator Report on Cancer in Europe 2019 - Disease Burden, Costs and Access to Medicines. IHE Report 2019:7. IHE: Lund, Sweden

References for graphs:

• Allemani, C et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
• Allemani, C et al. Global surveillance of trends in cancer survival 2000-2014 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries 

Uptake of Cancer Medicines

Note: Data pertaining to the uptake of cancer medicines was not available for Hodgkin lymphoma medicines across all European countries examined by IHE, in 2018.